WASHINGTON - U.S. health regulators on Thursday authorized Merck’s COVID-19 pill, known as molnupiravir — the second medication approved for at-home use to battle the rapidly-spreading omicron variant ...

WASHINGTON - Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 infections and end the pandemic, a new treatment has been developed that could be ...

The Food and Drug Administration on Thursday authorized a second antiviral pill for COVID but said it should not be preferred over other treatments. The FDA cleared the pill, developed by Merck and ...